Tackling multiple antibiotic resistance in enteropathogenic Escherichia coli (EPEC) clinical isolates: a diarylheptanoid from Alpinia officinarum shows promising antibacterial and immunomodulatory activity against EPEC and its lipopolysaccharide-induced inflammation

International Journal of Antimicrobial Agents

Volumn 33, Issue 3, 2009, Pages 244-250

  Subramanian, Krishnan ^a   Selvakkumar, Chinnasamy ^a   Vinaykumar, Kontham Sanathkumar ^a   Goswami, Nabajyoti ^a   Meenakshisundaram, Sankaranarayanan ^a   Balakrishnan, Arun ^b   Lakshmi, Baddireddi Subhadra ^a  

^a ANNA UNIVERSITY   (India)

^b Piramal Enterprises Limited   (India)

Author keywords

Antibacterial; Diarylheptanoid; EPEC; Immunomodulatory; Multidrug resistance

Indexed keywords

ALPINIA OFFICINARUM EXTRACT; DNA TOPOISOMERASE (ATP HYDROLYSING); HEPTANE DERIVATIVE; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG;

ALIPINIA OFFICINARUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; COMPUTER MODEL; DRUG ISOLATION; DRUG STRUCTURE; ENTEROPATHOGENIC ESCHERICHIA COLI; HUMAN; HUMAN CELL; IMMUNOMODULATION; INFECTION; INFLAMMATION; MEDICINAL PLANT; MOLECULE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; ZINGIBERACEAE;

ALPINIA; ANTI-BACTERIAL AGENTS; COMPUTATIONAL BIOLOGY; DIARYLHEPTANOIDS; DNA GYRASE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROPATHOGENIC ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HUMANS; IMMUNOLOGIC FACTORS; LEUKOCYTES, MONONUCLEAR; MODELS, MOLECULAR; PROTEIN BINDING;

EID: 60249091673     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.08.032     Document Type: Article

References (40)

1. Clarke S.C., Haigh R.D., Freestone P.P., and Williams P.H. Virulence of enteropathogenic Escherichia coli, a global pathogen. Clin Microbiol Rev 16 (2003) 365-378
2. Ruchaud-Sparagano M.H., Maresca M., and Kenny B. Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function. Cell Microbiol 9 (2007) 1909-1921
3. Celli J., Olivier M., and Finlay B.B. Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3-kinase-dependent pathways. EMBO J 20 (2001) 1245-1258
4. Chakravortty D., and Kumar K.S. Interaction of lipopolysaccharide with human small intestinal lamina propria fibroblasts favors neutrophil migration and peripheral blood mononuclear cell adhesion by the production of proinflammatory mediators and adhesion molecules. Biochim Biophys Acta 1453 (1999) 261-272
5. Guerra B., Junker E., Schroeter A., Helmuth R., Guth B.E., and Beutin L. Phenotypic and genotypic characterization of antimicrobial resistance in Escherichia coli O111 isolates. J Antimicrob Chemother 57 (2006) 1210-1214
6. Lim Y.S., Ngan C.C., and Tay L. Enteropathogenic Escherichia coli as a cause of diarrhoea among children in Singapore. J Trop Med Hyg 95 (1992) 339-342
7. Moyenuddin M., Wachsmuth I.K., Moseley S.L., Bopp C.A., Blake P.A., and Serotype. Antimicrobial resistance, and adherence properties of Escherichia coli strains associated with outbreaks of diarrheal illness in children in the United States. J Clin Microbiol 27 (1989) 2234-2239
8. Subramanian K., Selvakkumar C., Meenakshisundaram S., Balakrishnan A., and Lakshmi B.S. Extract of Alpinia officinarum suppresses enteropathogenic Escherichia coli (EPEC) lipopolysaccharide (LPS) induced inflammation in J774 A.1 macrophages. J Health Sci 54 (2008) 112-117
9. Prins J.M., van Deventer S.J., Kuijper E.J., and Speelman P. Clinical relevance of antibiotic-induced endotoxin release. Antimicrob Agents Chemother 38 (1994) 1211-1218
10. Lewis K., and Ausubel F.M. Prospects for plant-derived antibacterials. Nat Biotechnol 4 (2006) 1504-1507
11. Yadav P.N., Liu Z., and Rafi M.M. A diarylheptanoid from lesser galangal (Alpinia officinarum) inhibits proinflammatory mediators via inhibition of mitogen-activated protein kinase, p44/42, and transcription factor nuclear factor-kappa B. J Pharmacol Exp Ther 305 (2003) 925-931
12. Alves L.V., Temporal R.M., Cysne-Finkelstein L., and Leon L.L. Efficacy of a diarylheptanoid derivative against Leishmania amazonensis. Mem Inst Oswaldo Cruz 98 (2003) 553-555
13. Thomas E., Shanmugam J., and Rafi M.M. Antibacterial activity of plants belonging to Zingiberaceae family. Biomedicine 16 (1996) 15-20
14. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
15. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. 8th ed. Approved standard M2-A8. Wayne, PA: NCCLS; 2008.
16. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Twelfth informational supplement. M100-S12. Wayne, PA: NCCLS; 2002. Tables 2A-I, Zone diameter interpretative standards and equivalent minimum inhibitory concentration breakpoints.
17. Morais Cabral J.H., Jackson A.P., Smith C.V., Shikotra N., Maxwell A., and Liddington R.C. Crystal structure of the breakage-reunion domain of DNA gyrase. Nature 388 (1997) 903-906
18. Morris G.M., Goodsell D.S., Halliday R.S., Huey R., Hart W.E., Belew R.K., et al. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19 (1998) 1639-1662
19. Heddle J., and Maxwell A. Quinolone-binding pocket of DNA gyrase: role of GyrB. Antimicrob Agents Chemother 46 (2002) 1805-1815
20. Ostrov D.A., Hernandez Prada J.A., Corsino P.E., Finton K.A., Le N., and Rowe T.C. Discovery of novel DNA gyrase inhibitors by high-throughput virtual screening. Antimicrob Agents Chemother 51 (2007) 3688-3698
21. Lee V.T., and Schneewind O. Protein secretion and the pathogenesis of bacterial infections. Genes Dev 15 (2001) 1725-1752
22. Berkes J., Viswanathan V.K., Savkovic S.D., and Hecht G. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 52 (2003) 439-451
23. Mumy K.L., and McCormick B.A. Events at the host-microbial interface of the gastrointestinal tract. II. Role of the intestinal epithelium in pathogen-induced inflammation. Am J Physiol Gastrointest Liver Physiol 288 (2005) G854-G859
24. Chen G., Li J., Ochani M., Rendon-Mitchell B., Qiang X., Susarla S., et al. Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms. J Leukoc Biol 76 (2004) 994-1001
25. Khan M.A., Bouzaris S., Ma C., Rosenberger C.M., Bergstom K.S.B., Gibson D.L., et al. Flagellin-dependent and -independent inflammatory responses following infection by enteropathogenic Escherichia coli and Citrobacter rodentium. Infect Immun 76 (2008) 1410-1422
26. Haller D., Bode C., Hammes W.P., Pfeifer A.M., Schiffrin E.J., and Blum S. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures. Gut 47 (2000) 79-87
27. Vila J., Vargas M., Casals C., Urassa H., Mshinda H., Schellemberg D., et al. Antimicrobial resistance of diarrheagenic Escherichia coli isolated from children under the age of 5 years from Ifakara, Tanzania. Antimicrob Agents Chemother 43 (1999) 3022-3024
28. Nys S., Okeke I.N., Kariuki S., Dinant G.J., Driessen C., and Stobberingh E.E. Antibiotic resistance of faecal Escherichia coli from healthy volunteers from eight developing countries. J Antimicrob Chemother 54 (2004) 952-955
29. Bradford P.A., Petersen P.J., Fingerman I.M., and White D.G. Characterization of expanded-spectrum cephalosporin resistance in E. coli isolates associated with bovine calf diarrhoeal disease. J Antimicrob Chemother 44 (1999) 607-610
30. Pandey M., Khan A., Das S.C., Sarkar B., Kahali S., Chakraborty S., et al. Association of cytolethal distending toxin locus cdtB with enteropathogenic Escherichia coli isolated from patients with acute diarrhea in Calcutta, India. J Clin Microbiol 41 (2003) 5277-5281
31. Roy P., Purushothaman V., Kotteswaran A., and Dhillon A.S. Isolation, characterization and antimicrobial drug resistance pattern of Escherichia coli isolated from Japanese quail and their environment. J Appl Poult Res 15 (2006) 442-446
32. Denyer S.P., and Maillard J.Y. Cellular impermeability and uptake of biocides and antibiotics in Gram-negative bacteria. J Appl Microbiol 92 Suppl. (2002) 35S-45S
33. Lien E.J., Hansch C., and Anderson S.M. Structure-activity correlations for antibacterial agents on Gram-positive and Gram-negative cells. J Med Chem 11 (1968) 430-441
34. Alakomi H.L., Puupponen-Pimia R., Aura A.M., Helander I.M., Nohynek L., Oksman-Caldentey K.M., et al. Weakening of Salmonella with selected microbial metabolites of berry-derived phenolic compounds and organic acids. J Agric Food Chem 55 (2007) 3905-3912
35. Gauthier A., Robertson M.L., Lowden M., Ibarra J.A., Puente J.L., and Finlay B.B. Transcriptional inhibitor of virulence factors in enteropathogenic Escherichia coli. Antimicrob Agents Chemother 49 (2005) 4101-4109
36. Gruger T., Nitiss J.L., Maxwell A., Zechiedrich E.L., Heisig P., Seeber S., et al. A mutation in Escherichia coli DNA gyrase conferring quinolone resistance results in sensitivity to drugs targeting eukaryotic topoisomerase II. Antimicrob Agents Chemother 48 (2004) 4495-4504
37. Rai D., Singh J.K., Roy N., and Panda D. Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity. Biochem J 410 (2008) 147-155
38. Erickson H.P. FtsZ, a tubulin homologue in prokaryote cell division. Trends Cell Biol 7 (1997) 362-367
39. Sugino A., Peebles C.L., Kreuzer K.N., and Cozzarelli N.R. Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. Proc Natl Acad Sci USA 74 (1977) 4767-4771
40. Boehm H.J., Boehringer M., Bur D., Gmuender H., Huber W., Klaus W., et al. Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimisation. A promising alternative to random screening. J Med Chem 43 (2000) 2664-2674